2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
5
Venous Thromboembolism
4
Venous Thrombosis
3
Pulmonary Embolism
3
Thrombosis
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Hot Flashes
1
Embolism
1
Cushing Syndrome
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Non-small Cell Lung Cancer
1
Interventions
edoxaban
1
apixaban
1
Warfarin
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Dalteparin
1
Dabigatran
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Embolism
×
Dabigatran
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled